A Clinical Trial to study the effect of two drugs Vortioxetine and Escitalopram in patients of Depression.
Phase 4
Not yet recruiting
- Conditions
- Health Condition 1: F330- Major depressive disorder, recurrent, mild
- Registration Number
- CTRI/2020/12/029949
- Lead Sponsor
- Dr Pragya Jain
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosis of depression as per ICD-10
HDRS score more than 12
willing to give written informed consent
Exclusion Criteria
Patients with pre-existing sexual dysfunction or cognitive dysfunction independent of depression
Patients with any major medical or surgical illness
Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in HAM-D, HAM-A, SOFAS, PGI BBD-Memory scale scoresTimepoint: baseline, 4 and 8 weeks
- Secondary Outcome Measures
Name Time Method Change in sexual functioningTimepoint: 8 weeks